Research and Markets (http://www.researchandmarkets.com/research/skxjsz/gastrointestinal) has announced the addition of the "Gastrointestinal Tract Cancer-Pipeline Insights, 2016" report to their offering.
Gastrointestinal Tract Cancer-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Gastrointestinal Tract Cancer. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Gastrointestinal Tract Cancer.
The report also assesses the Gastrointestinal Tract Cancer therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
- The report provides competitive pipeline landscape of Gastrointestinal Tract Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Gastrointestinal Tract Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Gastrointestinal Tract Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Gastrointestinal Tract Cancer Overview
- Gastrointestinal Tract Cancer Pipeline Therapeutics
- Gastrointestinal Tract Cancer Therapeutics under Development by Companies
- Gastrointestinal Tract Cancer Filed and Phase III Products
- Comparative Analysis
- Gastrointestinal Tract Cancer Phase II Products
- Gastrointestinal Tract Cancer Phase I and IND Filed Products
- Gastrointestinal Tract Cancer Discovery and Pre-Clinical Stage Products
- Gastrointestinal Tract Cancer - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Gastrointestinal Tract Cancer - Discontinued Products
- Gastrointestinal Tract Cancer - Dormant Products
- Companies Involved in Therapeutics Development for Gastrointestinal Tract Cancer
For more information visit http://www.researchandmarkets.com/research/skxjsz/gastrointestinal
View source version on businesswire.com: http://www.businesswire.com/news/home/20160126006278/en/